Droperidol in the interim management of severe Mania: Case reports and literature review

E. Sherwood Brown, Steven C. Dilsaver, Theron C. Bowers, Alan C. Swann

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


There is little information in the literature concerning the use of droperidol in psychiatry. This article presents three cases in which extremely agitated and treatment-refractory persons with mixed mania derived benefit from droperidol administered orally. Symptomatic improvement, including decreased agitation and intrusiveness, improved sleep, and decreased rates of sleep, was observed with the use of oral droperidol at doses ranging from 10-80 mg daily. The only adverse reaction was a dystomia in one patient. This article also reviews the limited available literature on the use of droperidol in psychiatry. Only eight English language articles describing the use of droperidol for psychosis or agitation were found. Future controlled studies to examine the usefulness of oral dosing of droperidol in mama are suggested.

Original languageEnglish (US)
Pages (from-to)316-318
Number of pages3
JournalClinical neuropharmacology
Issue number5
StatePublished - Sep 1998


  • Agitation
  • Depression
  • Droperidol
  • Mania
  • Oral dosing

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)


Dive into the research topics of 'Droperidol in the interim management of severe Mania: Case reports and literature review'. Together they form a unique fingerprint.

Cite this